CPIX - Cumberland Pharmaceuticals Non-GAAP EPS of $0.02 revenue of $10.1M
2023-11-07 16:43:48 ET
- Cumberland Pharmaceuticals press release ( NASDAQ: CPIX ): Q3 Non-GAAP EPS of $0.02.
- Revenue of $10.1M (-11.4% Y/Y).
- Company ended the third quarter with $88 million in total assets, $52 million in total liabilities, and $36 million of shareholders' equity.
For further details see:
Cumberland Pharmaceuticals Non-GAAP EPS of $0.02, revenue of $10.1M